Results 121 to 130 of about 297,519 (217)
Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in Mice. [PDF]
Microorganisms, 2022 Wu SJ +13 more
europepmc +1 more source
[Dengue treatments and vaccines].
Medecine sciences : M/SLa dengue est une maladie virale transmise par les moustiques du genre Aedes, dont l’incidence et l’aire de répartition sont en constante augmentation depuis les dernières décennies. Causant des fièvres hémorragiques dans les cas graves, elle touche principalement les zones tropicales et subtropicales du globe, et menace de s’étendre à de nouvelles ...
Brézillon-Dubus, Lazare +2 more
openaire +2 more sources
Current Dengue Virus Vaccine Developments and Future Directions
VirusesDengue fever (DF), a leading arboviral disease globally, is caused by the Dengue virus (DENV) and represents a significant public health concern, with an estimated 390 million cases reported annually.
Govindaraj Anumanthan +2 more
doaj +1 more source
Approaches of dengue control: vaccine strategies and future aspects
Frontiers in ImmunologyDengue, caused by the dengue virus (DENV), affects millions of people worldwide every year. This virus has two distinct life cycles, one in the human and another in the mosquito, and both cycles are crucial to be controlled. To control the vector of DENV,
Runa Akter +7 more
doaj +1 more source
Perspective of the ACIP dengue vaccines workgroup on the evaluation of assays for pre-vaccination screening [PDF]
Dengue-Paz-Bailey ...
core
Progress in dengue vaccine research: a review
Zhongguo gonggong weishengDatabases such as ClinicalTrials, PubMed, and China National Knowledge Infrastructure (CNKI) were used to search for studies on the research progress of different dengue vaccine development strategies in ongoing or completed global clinical trials ...
Guanting ZHANG +6 more
doaj +1 more source
Anti-dengue Vaccines: From Development to Clinical Trials. [PDF]
Front Immunol, 2020 Pinheiro-Michelsen JR +6 more
europepmc +1 more source